載入...

Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

BACKGROUND: Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART). METHODS: We systematically reviewed randomized controlled trials (RCTs) of DRV/r versus other reg...

全面介紹

Na minha lista:
書目詳細資料
發表在:AIDS Res Treat
Main Authors: Balayan, Tatevik, Horvath, Hacsi, Rutherford, George W.
格式: Artigo
語言:Inglês
出版: Hindawi 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634582/
https://ncbi.nlm.nih.gov/pubmed/29082041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/2345617
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!